<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="pmc">eid</journal-id>
      <journal-title>Emerging Infectious Diseases</journal-title>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">10081683</article-id>
      <article-id pub-id-type="pmc">2627701</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rotun</surname>
            <given-names>S. S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McMath</surname>
            <given-names>V.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schoonmaker</surname>
            <given-names>D. J.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maupin</surname>
            <given-names>P. S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tenover</surname>
            <given-names>F. C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hill</surname>
            <given-names>B. C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ackman</surname>
            <given-names>D. M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>United Hospital Medical Center (UHMC), Port Chester, New York, USA.</aff>
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>1999</year>
      </pub-date>
      <volume>5</volume>
      <issue>1</issue>
      <fpage>147</fpage>
      <lpage>149</lpage>
      <abstract>
        <p>A Staphylococcus aureus isolate with reduced susceptibility to vancomycin was obtained from a dialysis patient with a fatal case of bacteremia. Comparison of the isolate with two methicillin-resistant S. aureus (MRSA) isolated obtained from the same patient 4 months earlier suggests that the S. aureus with reduced susceptibility to vancomycin emerged from the MRSA strain with which the patient was infected. Atypical phenotypic characteristics, including weak or negative latex-agglutination test results, weak or negative-slide coagulase test results, heterogeneous morphologic features, slow rate of growth, and vancomycin susceptibility (by disk diffusion test) were observed.</p>
      </abstract>
    </article-meta>
  </front>
</article>
</pmc-articleset>
